Imricor Medical Systems, Inc (IMR) TRADING HALT SUSPENDED

20mins delayed


1 Year Return

Imricor Medical Systems, Inc Chart

Share price
Market Cap $286.46 million
Today's Movement
Prev. Close
Day Range -
Historical Stats
52w Range -
4w Avg Volume
4w Avg Turnover

IMR Statistics

27 November

542 / 2,246

ASX Size Rank

1yr Return

vs Sector (1yr)


vs ASX 200 (1yr)


$286.46 million

Market Cap

Share Issue

114.58 million

All Ords (%)


Short Sold


Current Fundamentals

27 November


PE Ratio

EPS ($)


Earnings Yield


NTA ($)



Dividend Yield

DPS ($)


Gross Div. Yield


Gross DPS ($)


Company Overview

Imricor Medical Systems Inc (IMR) is a US based medical device company that seeks to address the current issues with traditional x-ray-guided ablation procedures through the development of MRI-guided technology. The Company's primary product offering, the Vision-MR Ablation Catheter is specifically designed to work under real-time MRI guidance, with the intent of enabling higher success rates along with a faster and safer treatment compared to conventional procedures using x-ray guided catheters.

Imricor Medical Systems, Inc Logo

Corporate Details

Head Office: Burnsville Minnesot
Managing Director: Steve Wedan
GICS Sub-Industry: Health Care Equipment
Date Listed: 30 Aug 2019
Registry: Computershare
Similar Companies: FPH / COH / RMD / ANN / NAN

Upcoming Calendar

18 Feb 2021 Report (Prelim)
23 Apr 2021 Report (Annual)
24 Aug 2021 Report (Interim)

Dividend History

Ex-Date Amount Franking Type Payable
No dividends paid in the last 5 years

See Upcoming Dividends for all ASX companies.


Date Heading Pages File Size Time

Announcements provided by

Broker Consensus

The buy, hold and sell recommendations from Australian stockbroking firms are combined to form a "broker consensus". See the Consensus Data posts for more information.

IMR is not covered by a major broker,
or data from most recent compilation was omitted due
to not meeting QA guidelines.

Directors & Management

About the Data

Name Title Since Bio
Mr Peter McGregor Non-Executive Director May 2019
Ms Doris Engibous Non-Executive Director Apr 2019
Mr Steve Wedan Chief Executive Officer, President, Executive Chairman, Executive Director May 2006
Mr Mark Tibbles Non-Executive Director Sep 2014
Kobe Li Company Secretary N/A
Nick Twohy Director - Marketing N/A
Greg Englehardt Director - Sales N/A
Tom Lloyd Vice President - Clinical Research N/A
Dan Sunnarborg Vice President - Engineering N/A
Lori Milbrandt Vice President - Finance and Chief Financial Officer N/A
Gregg Stenzel Vice President - Operations N/A
Jennifer Weisz Vice President - Regulatory and Quality N/A

Director Transactions

About the Data

IMR directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
14/05/20 Peter McGregor Issued 71,010 $1.340 $95,153 Issue of options.
14/05/20 Doris Engibous Issued 66,571 $1.340 $89,205 Issue of options.
14/05/20 Steve Wedan Issued 579,187 $1.340 $776,110 Issue of options.
14/05/20 Mark Tibbles Issued 71,010 $1.340 $95,153 Issue of options.
31/12/19 Steve Wedan Issued 501 $1.194 $598 Conversion of convertible notes.
31/12/19 Steve Wedan Transfer 2,518,219 $1.195 $3,009,271 Off-market transfer.
31/12/19 Mark Tibbles Issued 2,897 $1.195 $3,461 Conversion of convertible notes.
24/12/19 Mark Tibbles Exercise 30,000 $0.341 $10,230 Exercise of options.
24/12/19 Mark Tibbles Buy +30,000 $0.341 $10,230 Exercise of options.

Shareholder Distribution

About the Data

Holding Size 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001 and over Total Shareholders
No. of Shareholders 84 121 56 188 146 595

Top 20 Shareholders

No data available. Most companies release Top 20 Shareholders data in their Annual Report but it's not compulsory.

IMR Share Price History

Date Close Change % Change Open High Low Volume Turnover

IMR Historical Data

Download up to 20 years of share price history.

Year Closing Price (30 June) Last Trade
2020 $1.49 30 June

Offical data as published by ASX. See more Data Downloads.

Company Details

Principal Activity: Design, manufacture and sell MRI-compatible products for cardiac catheter ablation procedures to treat arrhythmias.

Incorporated: --

400 Gateway Bvd
Burnsville Minnesot USA 55337

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.